药物对比
Linagliptin vs Acarbose
比较 Linagliptin（Tradjenta）与 Acarbose（Precose）治疗2型糖尿病。作用机制、副作用、疗效及适用性方面的差异。
此页面暂无可用的对比维度。
临床背景
This comparison arises when choosing an oral add-on agent for type 2 diabetes after metformin, weighing DPP-4 inhibition against alpha-glucosidase inhibition.
结论
Linagliptin is generally better tolerated and more convenient, but Acarbose may suit patients focused on post-meal glucose control.
全部药物对比